Getinge (OTCMKTS:GNGBY – Get Free Report) posted its quarterly earnings results on Friday. The company reported $0.38 earnings per share (EPS) for the quarter, Zacks reports. Getinge had a net margin of 6.92% and a return on equity of 10.39%.
Getinge Stock Performance
GNGBY stock opened at $21.70 on Friday. The firm has a market cap of $5.91 billion, a PE ratio of 23.59 and a beta of 0.96. The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.27. The stock has a 50-day moving average price of $20.57 and a 200-day moving average price of $21.32. Getinge has a 1-year low of $18.99 and a 1-year high of $24.67.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised Getinge to a “hold” rating in a research note on Thursday, April 23rd. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.
About Getinge
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Featured Articles
- Five stocks we like better than Getinge
- J.B. Hunt Stock Could Reach $340 as Trucking Capacity Shrinks
- The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
